| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_96ec3985e3ce9b24614fb87bf51a4f12 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-525
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567 |
| filingDate |
2007-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0cf9e4f673734e09515889aa17e4211e |
| publicationDate |
2012-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
PE-20120375-A1 |
| titleOfInvention |
PHARMACEUTICAL COMPOSITION CONTAINING A TETRAHYDROPHOLIC ACID |
| abstract |
REFERS TO A PHARMACEUTICAL COMPOSITION INCLUDING: A) A PROGESTAGEN SUCH AS DROSPIRENONE IN A QUANTITY OF 2.5 TO 3.5MG; B) A ESTROGEN SUCH AS ETHINYLESTRADIOL IN AN AMOUNT OF 0.015 TO 0.035MG; C) A CALCIUM SALT OF 5-METHYL- (6S) -TETRAHYDROPHOLIC ACID IN A QUANTITY OF 0.1 TO 5MG; D) MICROCRYSTALLINE CELLULOSE IN A QUANTITY OF 10 TO 80MG; AND E) LACTOSE MONOHYDRATE IN A QUANTITY OF 10 TO 80MG. IT ALSO REFERS TO A COMPOSITION PREPARATION PROCEDURE. SUCH COMPOSITION IS USEFUL AS AN ORAL CONTRACEPTIVE |
| priorityDate |
2006-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |